{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:40:54Z","timestamp":1773510054322,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI","award":["R01CA131965"],"award-info":[{"award-number":["R01CA131965"]}]},{"name":"NIH\/NCI","award":["P50CA083636"],"award-info":[{"award-number":["P50CA083636"]}]},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wendy Feuer Fund for the Prevention and Treatment of Ovarian Cancer"},{"name":"Cori and Tony Bates Novel Technologies for Cancer Prevention Fund"},{"DOI":"10.13039\/100002300","name":"Marsha Rivkin Center for Ovarian Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ygyno.2015.12.017","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T23:03:10Z","timestamp":1450738990000},"page":"221-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Genetic characterization of early onset ovarian carcinoma"],"prefix":"10.1016","volume":"140","author":[{"given":"Sarah S.","family":"Bernards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara M.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy J.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2015.12.017_bb0005","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin. 2014 Jan\u2013Feb"},{"key":"10.1016\/j.ygyno.2015.12.017_bb0010","unstructured":"SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html (accessed 5-11-2015)."},{"issue":"5","key":"10.1016\/j.ygyno.2015.12.017_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.017_bb0020","unstructured":"(c) National Comprehensive Cancer Network, Inc., 2015. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Breast and\/or Ovarian Cancer Genetic Assessment V.1.2015. All rights reserved. http:\/\/www.nccn.org (15 May 2015, date last accessed). NATIONAL COMPREHENSIVE CANCER NETWORK\u00ae, NCCN\u00ae, NCCN GUIDELINES\u00ae, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc."},{"issue":"44","key":"10.1016\/j.ygyno.2015.12.017_bb0025","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.017_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1342 un-selected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2015.12.017_bb0035","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2015.12.017_bb0040","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/bjc.2012.452","article-title":"Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer","volume":"107","author":"Pal","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.ygyno.2015.12.017_bb0045","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation\u2014positive women with ovarian cancer: a report from the Australian ovarian cancer study group","volume":"30","author":"Alsop","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ygyno.2015.12.017_bb0050","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.017_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10689-013-9664-5","article-title":"Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention","volume":"12","author":"Lu","year":"2013","journal-title":"Familial Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2015.12.017_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.017_bb0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2012.09.009","article-title":"Loss of function germline mutations in RAD51D in women with ovarian carcinoma","volume":"127","author":"Wickramanayake","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2015.12.017_bb0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ygyno.2015.12.017_bb0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.955","article-title":"Mutations in BRIP1 confer high risk of ovarian cancer","volume":"43","author":"Rafnar","year":"2011","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ygyno.2015.12.017_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ygyno.2015.12.017_bb0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1399-0004.2012.01917.x","article-title":"Germline RAD51C mutations in ovarian cancer susceptibility","volume":"83","author":"Coulet","year":"2013","journal-title":"Clin. Genet."},{"issue":"16","key":"10.1016\/j.ygyno.2015.12.017_bb0090","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1093\/hmg\/ddr229","article-title":"RAD51C is a susceptibility gene for ovarian cancer","volume":"20","author":"Pelttari","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2015.12.017_bb0095","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","author":"Song","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.12.017_bb0100","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1086\/302671","article-title":"The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study","volume":"65","author":"Stratton","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ygyno.2015.12.017_bb0105","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0b013e3182a1cf71","article-title":"Added value of family history in counseling about risk of BRCA1\/2 mutation in early-onset epithelial ovarian cancer","volume":"23","author":"Arts-de Jong","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"28","key":"10.1016\/j.ygyno.2015.12.017_bb0110","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing","volume":"107","author":"Walsh","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.ygyno.2015.12.017_bb0115","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2010.34.2980","article-title":"Secondary somatic mutations restoring BRCA1\/2 predict chemotherapy resistance in hereditary ovarian carcinomas","volume":"29","author":"Norquist","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.12.017_bb0120","unstructured":"Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, and Gulsuner S, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. In press."},{"issue":"26","key":"10.1016\/j.ygyno.2015.12.017_bb0125","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2015.12.017_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"J. Natl Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2015.12.017_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2004.11.054","article-title":"Histologic subtypes and laterality of primary epithelial ovarian tumors","volume":"97","author":"Boger-Megiddo","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.12.017_bb0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ygyno.2005.02.022","article-title":"Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer","volume":"97","author":"Gotlieb","year":"2005","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815302201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815302201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:36:03Z","timestamp":1620826563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815302201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0090825815302201"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic characterization of early onset ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}